Can Biosimulation Provide the Key to Unlocking the Neurodegenerative Disease Development Challenge?
By Professor Piet van der Graaf, Ph.D., and Hugo Geerts, Ph.D. Neurodegenerative diseases (NDs) affect…
Certara2021 年 3 月 10 日
PK Submit CDISC Technology
PK Submit automates the time consuming, error-prone and complex task of creating CDISC domains as…
Certara2021 年 3 月 10 日
IQ WG Evaluation of PBPK Models for Organ-Impaired Populations
• The predictive performance of physiologically based pharmacokinetic(s) (PBPK) models for PK in renal impairment…
Jim Gallagher2021 年 3 月 10 日
Sealing Pharma Commercialization Deals: Creating Optimal Value for Investors
It is crucial for biotech developers to engage in early commercial market assessment to generate…
Jim Gallagher2021 年 3 月 5 日
Scientific Computing World: Connecting Science
Interconnection is an imperative for the modern laboratory, and seamless integration is mandatory from the…
Certara2021 年 3 月 4 日
Quantitative Systems Pharmacology for Drug Discovery and Development
Certara's Dr. Piet van der Graaf, Senior Vice President, Professor of Systems Pharmacology, Leiden University,…
Jim Gallagher2021 年 3 月 2 日
Certara Acquires AUTHOR!, a Regulatory and Biostatistics Services Firm in Europe
Broadens European footprint with integrated regulatory services and statistical analysis PRINCETON, NJ.— 2021 年 3 月 2 日–…
Certara2021 年 3 月 2 日
